Largo

MMEDF over 3.41

OTC name in the cutting-edge field of medical psilocybin is back in the consolidation zone. Can accumulate shares here or wait for the breakout confirmation to play to recent highs.
biotechbiotechnologyChart PatternshealthcaremedicinepsilocybinshroomboomTrend Analysis

También en:

Exención de responsabilidad